- Home
- YQ vs LSTA Comparison
YQ vs LSTA Comparison
Compare YQ & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YQ | LSTA |
|---|---|---|
| Founded | 2012 | 1980 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Misc Health and Biotechnology Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 28.9M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | YQ | LSTA |
|---|---|---|
| Price | $2.61 | $3.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 9.2K | ★ 30.2K |
| Earning Date | 06-09-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,283,868.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 56.90 |
| 52 Week Low | $1.70 | $1.81 |
| 52 Week High | $6.45 | $5.07 |
Technical Indicators
Market Signals| Indicator | YQ | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 47.95 |
| Support Level | $2.44 | $3.02 |
| Resistance Level | $2.63 | $3.41 |
| Average True Range (ATR) | 0.19 | 0.11 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 43.61 | 87.76 |
Price Performance
Historical ComparisonAbout YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is engaged in providing education and education technology services in the People's Republic of China (PRC) with a focus on the Teaching and Learning SaaS offerings. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.